tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Leap Therapeutics Granted Extension by Nasdaq
PremiumCompany AnnouncementsLeap Therapeutics Granted Extension by Nasdaq
1M ago
Leap Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Leap Therapeutics Reports Q2 2025 Financial Results
2M ago
Leap Therapeutics Completes Promising Phase 2 Cancer Study
Premium
Company Announcements
Leap Therapeutics Completes Promising Phase 2 Cancer Study
3M ago
Leap Therapeutics Reports Positive Clinical Data and Financial Results
PremiumCompany AnnouncementsLeap Therapeutics Reports Positive Clinical Data and Financial Results
7M ago
Leap Therapeutics reports Q4 EPS (37c) vs. (46c) last year
Premium
The Fly
Leap Therapeutics reports Q4 EPS (37c) vs. (46c) last year
7M ago
Leap Therapeutics updated preliminary data from Part B of the DeFianCe study
Premium
The Fly
Leap Therapeutics updated preliminary data from Part B of the DeFianCe study
7M ago
Leap Therapeutics price target lowered to $3 from $15 at Piper Sandler
PremiumThe FlyLeap Therapeutics price target lowered to $3 from $15 at Piper Sandler
9M ago
Leap Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Leap Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
9M ago
Leap Therapeutics downgraded to Neutral from Outperform at Baird
Premium
The Fly
Leap Therapeutics downgraded to Neutral from Outperform at Baird
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100